tiprankstipranks
Trending News
More News >
Revive Therapeutics Ltd (TSE:RVV)
:RVV
Canadian Market

Revive Therapeutics (RVV) Financial Statements

Compare
132 Followers

Revive Therapeutics Financial Overview

Revive Therapeutics's market cap is currently C$25.11M. The company's EPS TTM is C$-0.001; its P/E ratio is -4.56; Revive Therapeutics is scheduled to report earnings on February 27, 2026, and the estimated EPS forecast is C$―. See an overview of income statement, balance sheet, and cash flow financials.
Sep 25Sep 24Sep 23Sep 22Sep 21
Income Statement
Total RevenueC$ 0.00C$ 0.00C$ 0.00C$ 0.00C$ 0.00
Gross ProfitC$ -248.00C$ -328.00C$ -434.00C$ -578.00C$ -775.00
Operating IncomeC$ -1.65MC$ -3.29MC$ -5.52MC$ -17.83MC$ -18.50M
EBITDAC$ -11.01MC$ -5.60MC$ -5.52MC$ -17.74MC$ -18.57M
Net IncomeC$ -11.01MC$ -5.62MC$ -6.32MC$ -17.83MC$ -20.20M
Balance Sheet
Cash & Short-Term InvestmentsC$ 24.56KC$ 773.07KC$ 2.09MC$ 3.92MC$ 16.60M
Total AssetsC$ 205.02KC$ 10.64MC$ 14.25MC$ 17.07MC$ 29.81M
Total DebtC$ 66.87KC$ 25.22KC$ 219.69KC$ 327.73KC$ 415.84K
Net DebtC$ 42.31KC$ -797.85KC$ -1.87MC$ -3.59MC$ -16.18M
Total LiabilitiesC$ 3.66MC$ 3.40MC$ 3.60MC$ 4.46MC$ 999.68K
Stockholders' EquityC$ -3.46MC$ 7.23MC$ 10.65MC$ 12.60MC$ 28.81M
Cash Flow
Free Cash FlowC$ -807.66KC$ -3.29MC$ -6.03MC$ -13.06MC$ -11.31M
Operating Cash FlowC$ -807.66KC$ -3.29MC$ -6.03MC$ -13.06MC$ -8.31M
Investing Cash FlowC$ -30.00KC$ 0.00C$ 0.00C$ 0.00C$ -2.72M
Financing Cash FlowC$ 39.15KC$ 1.98MC$ 4.20MC$ 376.35KC$ 26.24M
Currency in CAD

Revive Therapeutics Earnings and Revenue History

Revive Therapeutics Debt to Assets

Revive Therapeutics Cash Flow

Revive Therapeutics Forecast EPS vs Actual EPS